Cite
Supplementary Table 1 from Increased TGF-α as a Mechanism of Acquired Resistance to the Anti-EGFR Inhibitor Cetuximab through EGFR–MET Interaction and Activation of MET Signaling in Colon Cancer Cells
MLA
Fortunato Ciardiello, et al. Supplementary Table 1 from Increased TGF-α as a Mechanism of Acquired Resistance to the Anti-EGFR Inhibitor Cetuximab through EGFR–MET Interaction and Activation of MET Signaling in Colon Cancer Cells. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0c03ea4d84dab47df883c5acc363d305&authtype=sso&custid=ns315887.
APA
Fortunato Ciardiello, Roberto Bianco, Liberato Berrino, Elena D’Aiuto, Raffaele De Palma, Anna Nappi, Vincenzo Sforza, Anna Capasso, Floriana Morgillo, Sara Costantino, Loreta Pia Ciuffreda, Donata Vitagliano, Stefania Napolitano, Erika Martinelli, & Teresa Troiani. (2023). Supplementary Table 1 from Increased TGF-α as a Mechanism of Acquired Resistance to the Anti-EGFR Inhibitor Cetuximab through EGFR–MET Interaction and Activation of MET Signaling in Colon Cancer Cells.
Chicago
Fortunato Ciardiello, Roberto Bianco, Liberato Berrino, Elena D’Aiuto, Raffaele De Palma, Anna Nappi, Vincenzo Sforza, et al. 2023. “Supplementary Table 1 from Increased TGF-α as a Mechanism of Acquired Resistance to the Anti-EGFR Inhibitor Cetuximab through EGFR–MET Interaction and Activation of MET Signaling in Colon Cancer Cells,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0c03ea4d84dab47df883c5acc363d305&authtype=sso&custid=ns315887.